Table 2: AA, AOD, and AOA characteristics.


Median medical history prior to immunotherapy (m)39.5118.472
Median OS (m)20.518.813.3
Median PFS (m)
Median interval PFS/death (m)15.915.45.5
6 months PFS (%)37.533.366
12 months PFS (%)37.52550
24 months PFS (%)302525
6 months OS (%)94.292.375
12 months OS (%)76.57762.5
24 months OS (%)41.239.646.9

OS: Overall survival, PFS: progression free survival, AA: anaplastic astrocytoma, AOD: anaplastic oligodendroglioma, AOA: anaplastic oligoastrocytoma.